IGF1 and obesity disorder: In both human obesity and DIO rat models, the highly pulsatile GH secretion is generally decreased [47, 48], while the effects on IGF-1, the major mediator and marker of GH action over time, and peripheral tissues have been far from concordant [49, 50].